These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31065924)

  • 21. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
    Zuo W; Chen J; Zhang S; Tang J; Liu H; Zhang D; Chen N
    Eur J Neurosci; 2014 Jun; 39(12):2107-18. PubMed ID: 24649933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.
    Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
    Stroke; 2002 Aug; 33(8):2100-4. PubMed ID: 12154270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The regulatory role of NF-κB in autophagy-like cell death after focal cerebral ischemia in mice.
    Li WL; Yu SP; Chen D; Yu SS; Jiang YJ; Genetta T; Wei L
    Neuroscience; 2013 Aug; 244():16-30. PubMed ID: 23558089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Protective Effects of Juglanin in Cerebral Ischemia Reduce Blood-Brain Barrier Permeability via Inhibition of VEGF/VEGFR2 Signaling.
    Liu J; Chen L; Zhang X; Pan L; Jiang L
    Drug Des Devel Ther; 2020; 14():3165-3175. PubMed ID: 32801650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia.
    Kilic E; Kilic U; Wang Y; Bassetti CL; Marti HH; Hermann DM
    FASEB J; 2006 Jun; 20(8):1185-7. PubMed ID: 16641198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.
    Suzuki Y; Nagai N; Yamakawa K; Muranaka Y; Hokamura K; Umemura K
    J Cereb Blood Flow Metab; 2015 Dec; 35(12):2021-31. PubMed ID: 26219596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH.
    Niego B; Broughton BRS; Ho H; Sobey CG; Medcalf RL
    Fluids Barriers CNS; 2017 Nov; 14(1):33. PubMed ID: 29157263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cathepsin K deficiency prevented stress-related thrombosis in a mouse FeCl
    Jin X; Yue X; Huang Z; Meng X; Xu S; Wu Y; Wan Y; Inoue A; Narisawa M; Hu L; Shi GP; Umegaki H; Murohara T; Lei Y; Kuzuya M; Cheng XW
    Cell Mol Life Sci; 2024 May; 81(1):205. PubMed ID: 38703204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astrocytic p75
    Qin X; Wang J; Chen S; Liu G; Wu C; Lv Q; He X; Bai X; Huang W; Liao H
    Glia; 2022 May; 70(5):892-912. PubMed ID: 35064700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
    Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
    Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 6-Gingerol attenuates microglia-mediated neuroinflammation and ischemic brain injuries through Akt-mTOR-STAT3 signaling pathway.
    Liu Y; Deng S; Zhang Z; Gu Y; Xia S; Bao X; Cao X; Xu Y
    Eur J Pharmacol; 2020 Sep; 883():173294. PubMed ID: 32681941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microvascular endothelial cells-derived microvesicles imply in ischemic stroke by modulating astrocyte and blood brain barrier function and cerebral blood flow.
    Pan Q; He C; Liu H; Liao X; Dai B; Chen Y; Yang Y; Zhao B; Bihl J; Ma X
    Mol Brain; 2016 Jun; 9(1):63. PubMed ID: 27267759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II).
    Larrue V; von Kummer R R; Müller A; Bluhmki E
    Stroke; 2001 Feb; 32(2):438-41. PubMed ID: 11157179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.
    Song HY; Chung JI; Jalin AMA; Ju C; Pahk K; Joung C; Lee S; Jin S; Kim BS; Lee KS; Ryu JM; Kim WK
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ginsenoside Rd enhances blood-brain barrier integrity after cerebral ischemia/reperfusion by alleviating endothelial cells ferroptosis via activation of NRG1/ErbB4-mediated PI3K/Akt/mTOR signaling pathway.
    Hu S; Fei Y; Jin C; Yao J; Ding H; Wang J; Liu C
    Neuropharmacology; 2024 Jun; 251():109929. PubMed ID: 38521230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosiglitazone ameliorates tissue plasminogen activator-induced brain hemorrhage after stroke.
    Li Y; Zhu ZY; Lu BW; Huang TT; Zhang YM; Zhou NY; Xuan W; Chen ZA; Wen DX; Yu WF; Li PY
    CNS Neurosci Ther; 2019 Dec; 25(12):1343-1352. PubMed ID: 31756041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium ferulate and n-butylidenephthalate combined with bone marrow stromal cells (BMSCs) improve the therapeutic effects of angiogenesis and neurogenesis after rat focal cerebral ischemia.
    Zhang Q; Zhao Y; Xu Y; Chen Z; Liu N; Ke C; Liu B; Wu W
    J Transl Med; 2016 Jul; 14(1):223. PubMed ID: 27465579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FGF17 protects cerebral ischemia reperfusion-induced blood-brain barrier disruption via FGF receptor 3-mediated PI3K/AKT signaling pathway.
    Huang WT; Chen XJ; Lin YK; Shi JF; Li H; Wu HD; Jiang RL; Chen S; Wang X; Tan XX; Chen KY; Wang P
    Eur J Pharmacol; 2024 May; 971():176521. PubMed ID: 38522639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential molecular targets of peroxynitrite in mediating blood-brain barrier damage and haemorrhagic transformation in acute ischaemic stroke with delayed tissue plasminogen activator treatment.
    Chen H; Chen X; Luo Y; Shen J
    Free Radic Res; 2018 Dec; 52(11-12):1220-1239. PubMed ID: 30468092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.